SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-4.1
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex4-1.htm

Chunk 3 of 5
Word Count: 1500
Character Count: 9560

Document Content:

distribution on the books of the Company; (ii) if the Company shall offer to all the holders of its Common Stock any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor; or (iii) a voluntary or involuntary dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed. 8.3 Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section 6 hereof, send notice to the Holder of such event and change (“Price Notice”). The Price Notice shall describe the event causing the change and the method of calculating same.

8.4 Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be
deemed to have been duly made when hand delivered, mailed by express mail or private courier service or sent via email: (i) if to the
registered Holder of this Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company,
to following address or to such other address as the Company may designate by notice to the Holder:

BioVentrix,
Inc.

Forbes Blvd., Suite 125

Mansfield,

Attention:
David Richmond

Email:
dave@Richmondbrothers.com

with
a copy (which shall not constitute notice) to:

Ellenoff
Grossman & Schole LLP

Avenue of the Americas

New
York, NY 10105

Attention:
Lawrence A. Rosenbloom, Esq.

Email:
lrosenbloom@egsllp.com

9. Miscellaneous.

9.1 Amendments.
The Company and the Holder may from time to time supplement or amend this Purchase Warrant without the approval of any of other holders
of any other Purchase Warrants issued in connection with the Offering and/or pursuant to Section 3 or Section 5 hereof in order to cure
any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other provisions
herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the Holder may jointly
deem necessary or desirable in their discretion.

9.2 Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Purchase Warrant.

Entire Agreement. This Purchase Warrant constitutes the entire agreement of the Company and the Holder with respect to the subject
matter hereof, and supersedes all prior promises, agreements and understandings, oral and written, with respect to the subject matter
hereof.

9.4 Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their
permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have
any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.

9.5 Governing
Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced
in the courts located in New York, New York, or in the United States District Court located in New York, New York, and irrevocably submits
to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and
that such courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in
Section 8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Purchase Warrant or the transactions contemplated hereby.

9.6 Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be
deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision
hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of
any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in
a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any
such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance
or non-fulfillment.

9.7 Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time
prior to the complete exercise of this Purchase Warrant by the Holder, if the Company and Benchmark enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or
a combination of both, then the Holder shall agree to such exchange and become a party to the Exchange Agreement.

[Signature
Page Follows]

WITNESS WHEREOF, the Company has caused this Representative’s Warrant to be signed by its duly authorized officer as of the [—]
day of [—], 2026.

BIOVENTRIX, INC.

Name:

Title:

Exhibit

FORM
OF NOTICE OF EXERCISE

BioVentrix, Inc.

Date:

The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for [●] shares of the common stock, $0.0001 par value per
share (the “Common Stock”), of BioVentrix, Inc., a Delaware corporation (the “Company”), and hereby
makes payment of $[●] (at the rate of $[●] per share of Common Stock) in payment of the Exercise Price pursuant thereto.
Please issue the shares of Common Stock as to which this Purchase Warrant is exercised in accordance with the instructions given below
and, if applicable, a new Purchase Warrant representing the number of shares of Common Stock for which this Purchase Warrant has not
been exercised.

The
undersigned hereby elects irrevocably to convert its right to purchase [●] shares of Common Stock under the Purchase Warrant for
[●] shares of Common Stock, as determined in accordance with the following formula:

Where,

X	=	The
number of shares of Common Stock to be issued to Holder;

Y	=	The
number of shares of Common Stock for which the Purchase Warrant is being exercised;

A	=	The
Fair Market Value of one share of Common Stock (which is equal to $[●]); and

B	=	The
Exercise Price (which is equal to $[●] per share of Common Stock)

The
undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement
with respect to the calculation shall be resolved by the Company in its sole discretion. Please issue the shares of Common Stock as to
which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing
the number of shares of Common Stock for which this Purchase Warrant has not been converted.

Name
of Investing Entity _________________________________________________

Signature

Name
of Authorized Signatory _________________________________________________

Title
of Authorized Signatory _________________________________________________

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

Name:

(Print
in Block Letters)

Address:

Exhibit

FORM
OF ASSIGNMENT

be executed by the registered Holder to effect a transfer of the within Purchase Warrant):

FOR
VALUE RECEIVED, __________________ does hereby sell, assign and transfer unto the right to purchase [●] shares of the common stock,
$0.0001 par value per share (the “Common Stock”), of BioVentrix, Inc., a Delaware corporation (the “Company”),
evidenced by the Purchase Warrant to _________________________________________________ and does hereby authorize the Company to transfer
such right on the books of the Company.

Dated:

Name
of Investing Entity _________________________________________________

Signature

Name
of Authorized Signatory _________________________________________________

Title
of Authorized Signatory _________________________________________________

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES